the use of pet and ctdna for risk stratification & to guide treatment decisions in hodgkin lymphoma
Published 1 year ago • 77 plays • Length 2:32Download video MP4
Download video MP3
Similar videos
-
1:34
pet-guided treatment: the new standard of care in hodgkin lymphoma?
-
1:37
the role of ctdna in hodgkin lymphoma
-
3:05
the benefits of pet in the prognosis and treatment of hl
-
2:15
the role of pet/ct in assessing early treatment response in patients with ndmm
-
2:03
novel treatment approaches for early-stage dlbcl
-
7:27
phase ii study of camidanlumab tesirine in r/r hodgkin lymphoma
-
1:25
the changing treatment landscape of hl: de-escalating treatment intensity while maintaining efficacy
-
1:28
how the standard of care for dlbcl is changing with the introduction of novel agents
-
6:13
phase i study of forimtamig, a gprc5dxcd3 bispecific antibody, in r/r multiple myeloma
-
0:51
the value of car-t cell therapy in r/r dlbcl
-
2:56
pet/ct in cancers of the skin by mark tulchinsky, m.d., facnm
-
1:08
the potential of tcrs for relapse management
-
2:33
what do you see as the future of pet imaging?
-
22:17
when, and when not, to use pet/ct part 1
-
1:31
lament of the dead cancer cell: hmgb1 and lymphoplegic tumor infiltrating lymphocytes (teaser)
-
4:05
your pet/ct exam
-
6:17
it's your case - 3mo mn domestic shorthair who has a 5-day history of difficulty breathing.
-
1:31
dr. schmaier on managing cancer-associated thrombosis